🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in South Korea / NCT06897501
Recruiting Not applicable

Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophagectomy

NCT06897501 · tracked via the Priya Life Science South Korea tracker
Phase
Not applicable
Started
2025-04-14
Last updated
2025-05-18

Condition(s) studied

One Lung Ventillation (OLV)

Investigational drug(s) / intervention(s)

bronchial blockerdouble-lumen endobronchial tube

bronchial blocker: Lung isolation for robot-assisted esophagectomy will be performed using bronchial blocker in this group.

double-lumen endobronchial tube: Lung isolation for robot-assisted esophagectomy will be performed using double-lumen endobronchial tube in this group.

Study summary

The goal of this clinical trial is to investigate whether the use of bronchial blocker could reduce the incidence of postoperative vocal cord palsy than the use of double-lumen endobronchial tube in robot-assisted esophagectomy.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 19 or older * American Society of Anesthesiologists physical status I - III * Elective robot-assisted esophagectomy * Any clinical stage of esophageal cancer * Patients who need recurrent laryngeal nerve lymph nodes resection Exclusion Criteria: * Patients who diagnosed vocal cord palsy or damage before surgery * Patients who need specific airway device due to airway problem * History of thoracic surgery * Emergency surgery * Combined surgery with other department * Pregnant or nursing women

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Samsung Medical Center Seoul South Korea Recruiting

More Samsung Medical Center trials in South Korea

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06897501 on ClinicalTrials.gov ↗ ← All trials in South Korea